News

19-11-2019

Accord and ADIENNE Enter into Exclusive Distribution Agreement for TEPADINA®

London, England and Lugano, Switzerland 19 November 2019 – Accord Healthcare Limited (“Accord”) and ADIENNE Pharma & Biotech S.A. (“ADIENNE”) have entered into an exclusive licencing and distribution agreement for the commercialisation of TEPADINA® (thiotepa) 15mg and 100mg lyophilized powder for injections.

Weiterlesen

18-04-2019

Healthcare – the most recognised company at the Global Generics & Biosimilar Awards 2018

We are delighted to announce that Accord Healthcare was the most recognised company at the Global

Weiterlesen

10-11-2017

Accord Healthcare gewinnt in 3 Kategorien der Global Generics & Biosimilars Awards 2017

Accord Healthcare war bei den diesjährigen Global Generics & Biosimilars Awards am 23. Oktober 2017 gleich in mehreren Kategorien in der engeren Auswahl.

Weiterlesen

25-05-2017

INTAS COMPLETES DEAL

Intas Pharmaceuticals completes deal to acquire Actavis UK & Ireland generics businesses.

Weiterlesen